Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma

Liver Transplantation

Volumn 12, Issue 6, 2006, Pages 912-919

  Takada, Yasutsugu ^a   Ueda, Mikiko ^a   Ito, Takashi ^a   Sakamoto, Seisuke ^a   Haga, Hironori ^a   Maetani, Yoji ^a   Ogawa, Kohei ^a   Kasahara, Mureo ^a   Oike, Fumitaka ^a   Egawa, Hiroto ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; RETREATMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; SURVIVAL;

EID: 33745511028     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20642     Document Type: Article

References (29)

1. Ringe B, Wittenkind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989;209:88-98.
2. Iwatsuki S, Gordon RD, Shaw BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202: 401-407.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients vIth cirrhosis. N Engl J Med 1996;334:693-699.
4. United Network for Organ Sharing. Policy 3.6. Organ Distribution: Allocation of Livers. Available at: http://www.unos.org. Accessed June 24, 2005.
5. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127(Suppl):S159-S166.
6. Esnaola NF, Mirza N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003;238:711-719.
7. Itamoto T, Nakahara H, Tashiro H, Ohdan H, Hino H, Ochi M, et al. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis. Am J Surg 2005; 189:167-172.
8. Ikeda M, Maeda S, Shibata J, Muta R, Ashihara H, Tanaka M, et al. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology 2004;66:24-31.
9. Schwartz M. Liver transplantation for hepatocellular carcimoma. Gastroenterology 2004:127(Suppl):S268-S276.
10. Todo S, Furukawa H, on behalf of the Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan. Ann Surg 2004;240:451-461.
11. Poon RT, Fan ST. Resection prior to liver transplantation for hepatocellular carcinoma: A strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl 2004; 10:813-815.
12. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003;75(Suppl):S37-S40.
13. Makuuchi M, Belghiti J, Belli G, Fan ST, Lau JWY, Ringe B, et al. IHPBA concordant classification of primary liver cancer: Working group report. J Hepatobiliary Pancreat Surg 2003,10:26-30.
14. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, et al. Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004;40:1396-1405.
15. Inomata Y, Uemoto S, Asonuma. K, Egawa H, Kiuchi T, Fujita S, et al. Right lobe graft in living donor liver transplantation. Transplantation 2000;69:258-264.
16. Kasahara M, Takada Y, Fujimoto Y, Ogura Y, Ogawa K, Uryuhara K, et al. Impact of with middle hepatic vein graft in right lobe living donor liver transplantation. Am J Transplant 2005;5:1339-1346.
17. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H. The evolution of immunosuppression with FK506 in pediatric living related liver transplantation. Transplantation 1996;61:247-252.
18. Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73:1959-1961.
19. Otto G, Heuschen U, Hofmann WJ, Krumm G, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis. Ann Surg 1998;227:424-432.
20. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitelev EP, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study. Hepatology 1997;26:444-450.
21. Jonas S, Bechstein WO, Steinmuller T Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
22. Hemming AW, Cattral MS, Reed AI, Van der Wert WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659.
23. Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma. Extending UNOS priority criteria. Ann Surg 2004; 239:142-149.
24. Adam R, Azoulay D, Castaining D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis. A reasonable strategy? Ann Surg 2003;38:508-519.
25. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Implications for a strategy of salvage transplantation. Ann Surg 2002;235:373-382.
26. Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707-716
27. Carr BI. Hepatocellular carcinoma: Current management and future trends. Gastroenterology 2004:127(Suppl): S218-S224.
28. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003;238:885-893.
29. Sala M, Fuster J, Llovet JM, Navasa M, Sole M, Varela M, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation. Liver Transplantation 2004; 10:1294-1300.